Klaus Kluck

5PUBLICATIONS
72CO-AUTHORS
Tissue engineeringPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 29, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer.

Eva Romanovsky, Michael Menzel, Klaus Kluck

|Aug 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvements.

Jan Budczies, Daniel Kazdal, Michael Menzel

|Oct 24, 2023
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.

Maria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm

|Oct 20, 2023
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.

Michael Menzel, Stephan Ossowski, Sebastian Kral

Pageof 1